Amnesty International today accused pharmaceutical companies producing COVID-19 vaccines of exacerbating an “unprecedented human rights crisis” by calling for two billion doses to be distributed to poor countries.
In a report entitled “Double dose of inequality: pharmaceutical companies and the COVID-19 vaccine crisis”, the NGO stresses that most of them do not prioritize the poorest countries.
The report is being released and a global conference on vaccines is expected today. US President Joe Biden has promised to announce additional commitments to vaccinate the population of the least developed countries.
«Vaccinating people is the only way out of this crisis. “It should be time to salute these companies, which created the vaccines so quickly, for their heroism,” Amnesty International Secretary-General Anies Kalamar said in a press release. “Instead, to the great shame and sorrow of all of us, the international blockade of the transfer of know-how by the big pharmaceutical companies and their maneuvers in favor of rich countries gave rise to a shortage of vaccines, which was entirely predictable and utterly catastrophic for so many but”.
The NGO examined their policy AstraZeneca, Pfizer/BioNTech, Moderna, Johnson & Johnson και Novavax – the latter vaccine has not yet been approved – in terms of human rights, pricing, intellectual property, know-how and technology sharing, dose sharing and transparency.
And he concluded that more or less, the six companies that developed vaccines “have not fulfilled their human rights responsibilities».
Of the 5.76 billion installments that have been disbursed, only 0.3% is distributed in countries with “low” incomes, while 79% in countries with “middle-upper” and “high” incomes, Amnesty emphasizes.
Pfizer, BioNTech and Moderna plan to raise a total of $ 130 billion by the end of 2022, according to the NGO, for which “profits should never be above human life.”
Although most of these companies ereceived “billions of dollars in government funding”, choose to “monopolize intellectual property, prevent the transfer of technology and aggressively limit measures that would allow the production of their vaccines to expand worldwide,” Amnesty International complains.
It calls on companies and governments to “change course” and distribute two billion doses to lower- and middle-income countries.
When the NGO contacted them before publishing the report, all companies except Novavax stated that they recognized that a fair and equitable distribution of vaccines, especially in lower-income countries, was out of the question, and outlined their efforts to this, without convincing Amnesty International.

Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.